260961 Sigma-AldrichDNA-PK Inhibitor II - CAS 154447-35-5 - Calbiochem
DNA-PK Inhibitor II, CAS 154447-35-5, is a cell-permeable, potent, specific, reversible, and ATP-competitive inhibitor of DNA-PK (IC50 = 230 nM).
More>> DNA-PK Inhibitor II, CAS 154447-35-5, is a cell-permeable, potent, specific, reversible, and ATP-competitive inhibitor of DNA-PK (IC50 = 230 nM). Less<<Synonyms: NU7026, DNA-Dependent Protein Kinase Inhibitor II, 2-(Morpholin-4-yl)-benzo[h]chromen-4-one, LY293646
Recommended Products
Overview
| Replacement Information |
|---|
Key Spec Table
| CAS # | Empirical Formula |
|---|---|
| 154447-35-5 | C₁₇H₁₅NO₃ |
| Product Information | |
|---|---|
| CAS number | 154447-35-5 |
| ATP Competitive | Y |
| Form | Crystalline solid |
| Hill Formula | C₁₇H₁₅NO₃ |
| Chemical formula | C₁₇H₁₅NO₃ |
| Reversible | Y |
| Structure formula Image | |
| Quality Level | MQ100 |
| Applications | |
|---|---|
| Application | DNA-PK Inhibitor II, CAS 154447-35-5, is a cell-permeable, potent, specific, reversible, and ATP-competitive inhibitor of DNA-PK (IC50 = 230 nM). |
| Biological Information | |
|---|---|
| Primary Target | DNA-PK |
| Primary Target IC<sub>50</sub> | 0.23 µM against DNA-PK |
| Purity | ≥95% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | Y |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN |
| 260961 | 0 |
Documentation
Required Licenses
| Title |
|---|
| PRODUCTO REGULADO POR LA SECRETARÍA DE SALUD |
DNA-PK Inhibitor II - CAS 154447-35-5 - Calbiochem SDS
| Title |
|---|
DNA-PK Inhibitor II - CAS 154447-35-5 - Calbiochem Certificates of Analysis
| Title | Lot Number |
|---|---|
| 260961 |
References
| Reference overview |
|---|
| Willmore, E., et al. 2004. Blood,103, 4659. Hollick, J.J., et al. 2003. Bioorg. Med. Chem. Lett. 13, 3083. Veuger, S.J., et al. 2003. Cancer Res. 63, 6008. Vlahos, C.J., et al. 1994. J. Biol. Chem. 269, 5241. |



